By A Mystery Man Writer
Alzheimer's Innovations, Alzheimer's Disease Research
BioVie Investor Deck, June 2021
NIDDK BioWorld
electromagnetic therapy
Novel insights into vulnerability and resilience in Parkinson's disease
Neurology/psychiatric
Bioarctic AB
BioVie (BIVI): Treating Alzheimer's, Parkinson's, Reversing The Biological Clock
BioVie Investor Deck, June 2021
Science BioWorld
BioVie achieves revised enrolment target in Alzheimer's trial
$27M brightens treatment resistant depression outlook
Intercept heads for FDA talks to 'Regenerate' filing for NASH hopeful obeticholic acid
BioVie Announces EfficacyData from Phase 3 Trial of NE3107 in Patientswith Mild to Moderate Alzheimer's Disease